Speciality
Spotlight

 




 

Urology


 

 




Nocturnal Enuresis

      

  • K Hialmas, E Hanson, A-L Hellstrom , et al [Sahigrenska Univ Hosp/ East, Goteborg, Sweden]


    Long-term Treatment with desmopressin in Children with Primary Monosymptomatic Nocturnal Enuresis An Open Multicentre Study



    Br J Urol 82 : 704-709, 1998


       


    Conclusions – One year of nasal desmopressin at doses of upto 40 mg/day was safe and effective in treating PMNE. Almost 2/3rd of these patients [61%] had 50% or greater decreases in their number of wet nights, and 18% of the patients became completely dry.

       


    Initial studies of desmopressin did not evaluate long term efficacy and safety. 

       


    In this open study, 7% of patients had no response to DDAVP Only 18% were completely dry on medication which is a lower percentage than the 25% response reported in short term studies.


        


    The number of patients “cured” with DDAVP did not exceed the annual spontaneous cure rate of 15%, but this is a safe, reasonably effective treatment of nocturnal enuresis.

        

 



 

  

Speciality Spotlight

 

 
Urology
 

 

Nocturnal Enuresis
      

  • K Hialmas, E Hanson, A-L Hellstrom , et al [Sahigrenska Univ Hosp/ East, Goteborg, Sweden]
    Long-term Treatment with desmopressin in Children with Primary Monosymptomatic Nocturnal Enuresis An Open Multicentre Study
    Br J Urol 82 : 704-709, 1998
       
    Conclusions – One year of nasal desmopressin at doses of upto 40 mg/day was safe and effective in treating PMNE. Almost 2/3rd of these patients [61%] had 50% or greater decreases in their number of wet nights, and 18% of the patients became completely dry.
       
    Initial studies of desmopressin did not evaluate long term efficacy and safety. 
       
    In this open study, 7% of patients had no response to DDAVP Only 18% were completely dry on medication which is a lower percentage than the 25% response reported in short term studies.
        
    The number of patients “cured” with DDAVP did not exceed the annual spontaneous cure rate of 15%, but this is a safe, reasonably effective treatment of nocturnal enuresis.
        

 

 

By |2022-07-20T16:42:39+00:00July 20, 2022|Uncategorized|Comments Off on Nocturnal Enuresis

About the Author: